Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Zoetis (ZTS)

Zoetis Appoints Stephanie Tilenius to Board, Effective December 1, 2025

Neutral Impact 2 of 5 leadership Written later

Zoetis Inc. said its Board appointed Stephanie Tilenius as a director, effective December 1, 2025, and will expand the Board from twelve to thirteen members at that time. The filing describes her background in digital health and technology, and it reports no arrangements with third parties and no reportable related party transactions. The change adds a director with digital health and AI experience and does not involve a change in financial results or guidance.

Key points

  • Board appointed Stephanie Tilenius on October 23, 2025; her term starts December 1, 2025.
  • Board size increases from twelve to thirteen members effective December 1, 2025.
  • She previously founded Vida Health, Inc. and served as its CEO from 2014 to 2023; she also held senior roles at Google, PayPal and eBay.
  • Company will enter into its standard indemnification agreement with her.

The filing

CompanyZoetis (ZTS)
Form8-K, current report
Filed with the SECOct 28, 2025, 8:33 AM ET
Accession number0001555280-25-000266

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.